Doctor profile · Federal record

Dr. Vanessa Escobar-Barboza, MD

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Obesity Medicine (Internal Medicine) Physician · Endocrinology, Diabetes & Metabolism Physician · Jersey City, NJ

  • NPI 1558580936
  • Accepts Medicare
  • 24 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
377 Jersey Ave Ste 220
Jersey City, NJ 073024396
(201) 915-2380
fax (551) 310-6730
Additional location
3601 Federal Hwy
Miami, FL 331373795
(305) 576-6611

Credentials & registration

NPPES · NUCC
NPI registered
April 2007 — 19 yrs on file
Profile last updated
July 19, 2024
Year of graduation
2002 — 24 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State licenses (2)
New Jersey #25MA09181900 · Florida #ME145390

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1558580936. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
77
Distinct HCPCS
3
Medicare allowed
$10,556
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 44 25 $139
99213 Established patient office or other outpatient visit, 20-29 minutes 19 11 $98
99204 New patient office or other outpatient visit, 45-59 minutes 14 14 $183

In context: peer comparison

Among 2 peers in this city , average services per provider: 34. This provider delivers 2.3× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$175
Transactions
10
Manufacturers
8
Payer (manufacturer) Industry Txns Amount
Celgene Corporation 2 $33.49
Xeris Pharmaceuticals, Inc. 2 $31.09
Abbott Laboratories 1 $23.75
Corcept Therapeutics 1 $22.26
Novo Nordisk Inc 1 $20.01
Boehringer Ingelheim Pharmaceuticals, Inc. 1 $16.00
Bayer Healthcare Pharmaceuticals Inc. 1 $15.09
Lilly USA, LLC 1 $13.33

By nature of payment

Food and Beverage
$175

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,065
Patients
243
Total drug cost
$543,159
Drug Type Claims Patients Total cost
Trulicity (Dulaglutide) Brand 153 33 $185,702
Farxiga (Dapagliflozin Propanediol) Brand 125 35 $87,408
Levothyroxine Sodium Generic 111 30 $1,468
Metformin Hcl Generic 109 38 $804
Jardiance (Empagliflozin) Brand 107 24 $82,342
Metformin Hcl Er (Metformin Hcl) Brand 107 33 $1,430
Atorvastatin Calcium Generic 77 21 $764
Ozempic (Semaglutide) Brand 46 0 $49,220
Januvia (Sitagliptin Phosphate) Brand 40 0 $31,022
Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) Brand 39 15 $19,141

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Vanessa Escobar-Barboza's medical specialty?
Dr. Vanessa Escobar-Barboza practices Endocrinology, Diabetes & Metabolism Physician in Jersey City, NJ.
Where does Dr. Vanessa Escobar-Barboza practice?
Dr. Vanessa Escobar-Barboza practices at 377 Jersey Ave Ste 220, Jersey City, NJ 073024396. Office phone: 2019152380.
What is Dr. Vanessa Escobar-Barboza's NPI?
Dr. Vanessa Escobar-Barboza's National Provider Identifier (NPI) is 1558580936, issued by NPPES.
Does Dr. Vanessa Escobar-Barboza accept Medicare assignment?
Yes. Dr. Vanessa Escobar-Barboza accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Vanessa Escobar-Barboza commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99213); New patient office or other outpatient visit (HCPCS 99204). Source: CMS Medicare Physician & Other Practitioners file.